CPT® Code 0627T

Percutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, unilateral or bilateral injection, with fluoroscopic guidance, lumbar; first level

The procedure described by CPT® Code 0627T involves the percutaneous injection of allogeneic cellular and/or tissue-based products into the intervertebral disc, specifically at the lumbar region. Allogeneic cells, often referred to as universal cells, are sourced from a single donor, such as umbilical cord blood, and are stored in a master cell bank. These cells are then processed to meet the specific therapeutic needs of the patient. The use of allogeneic mesenchymal cells or tissue-based products, which may include materials like bone marrow or umbilical tissue, aims to address intervertebral disc degeneration. This innovative approach is designed to alleviate pain and enhance the quality of the disc without resorting to invasive surgical methods, making it a more convenient alternative to autologous cell therapy, where the patient's own cells are used. During the procedure, local anesthesia is administered, and fluoroscopic imaging guidance is utilized to ensure accurate placement of the intradiscal injection. The injection is prepared with a specific number of cells tailored for the segment being treated. For billing purposes, CPT® Code 0627T is used to report the injection at the first level on one or both sides, while additional levels can be reported using CPT® Code 0629T when fluoroscopic guidance is employed, or CPT® Code 0630T for CT guidance.